Engineering a nanocluster-immobilized MOF@MOF architecture-based ratiometric fluorescence bioassay for sensing neurodegenerative disease-related acetylcholinesterase and inhibitor drugs.

Liu C, Li J, Wang F, Wang M.

Open source

DOI
10.1039/d6ay01083k
Published
2026-08-06
Container
Anal Methods
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1039/d6ay01083k,
  title = {Engineering a nanocluster-immobilized MOF@MOF architecture-based ratiometric fluorescence bioassay for sensing neurodegenerative disease-related acetylcholinesterase and inhibitor drugs.},
  author = {Liu C and  Li J and  Wang F and  Wang M.},
  year = {2026},
  journal = {Anal Methods},
  doi = {10.1039/d6ay01083k},
  url = {https://doi.org/10.1039/d6ay01083k}
}

RIS

TY  - JOUR
TI  - Engineering a nanocluster-immobilized MOF@MOF architecture-based ratiometric fluorescence bioassay for sensing neurodegenerative disease-related acetylcholinesterase and inhibitor drugs.
AU  - Liu C
AU  -  Li J
AU  -  Wang F
AU  -  Wang M.
PY  - 2026
JO  - Anal Methods
DO  - 10.1039/d6ay01083k
UR  - https://doi.org/10.1039/d6ay01083k
ER  - 

APA

C, L., J, L., F, W., & M., W. (2026). Engineering a nanocluster-immobilized MOF@MOF architecture-based ratiometric fluorescence bioassay for sensing neurodegenerative disease-related acetylcholinesterase and inhibitor drugs.. Anal Methods. https://doi.org/10.1039/d6ay01083k

Source records